Medicare Enrolled

Dr. Naveen Kella, M.D.

Urology Physician · San Antonio, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
9618 HUEBNER ROAD , SUITE 120, San Antonio, TX 78240
2106173670
In practice since 2006 (20 years)
NPI: 1154301182 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kella from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kella? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kella

Dr. Naveen Kella is an urology physician in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kella performed 4,765 Medicare services across 2,845 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kella received a total of $61,808 from 88 pharmaceutical and/or device companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kella is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 25% volume in TX$ $61,808 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,765
Medicare services
Top 25% in TX for urology physician
2,845
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~238 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Urinalysis, manual1,156$3$25
Office visit, established patient (30-39 min)1,007$85$1,107
Office visit, established patient (20-29 min)902$60$756
Bladder ultrasound after voiding815$7$131
New patient office visit (45-59 min)158$104$1,670
Diagnostic exam of bladder and urethra using an endoscope112$175$1,952
Complete ultrasound scan behind abdominal cavity102$77$1,156
Drug injection, under skin or into muscle96$11$171
Ultrasound scan of pelvic region through rectum93$96$1,318
New patient office visit (30-44 min)54$76$1,100
Simple insertion of temporary bladder tube39$42$638
Simple bladder irrigation and/or instillation36$58$768
Electronic assessment of bladder emptying36$9$148
Biopsy of prostate gland34$158$2,574
Ultrasonic guidance for needle placement34$44$584
Removal of lymph nodes of both sides of pelvis using an endoscope21$243$6,895
Surgical removal of prostate and surrounding lymph nodes using an endoscope21$866$14,917
Dilation of urethra using an endoscope17$237$3,085
Destruction of prostate tissue using radiofrequency induced heated water vapor16$1,251$18,937
Ultrasound scan of scrotum16$66$1,079
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$61,808
Total received (2018-2024)
Avg $8,830/year across 7 years
Top 5% in TX for urology physician
88
Companies
580
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25,351 (41.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,029 (37.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,428 (21.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16,485
2023
$6,718
2022
$17,842
2021
$14,382
2020
$1,300
2019
$2,010
2018
$3,070

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$11,821
Olympus America Inc.
$10,143
Telix Pharmaceuticals
$8,246
Profound Medical Corp.
$7,533
Acerus Pharmaceuticals Corporation
$6,938
NeoTract Inc.
$2,430
Olympus Corporation of the Americas
$2,291
Janssen Biotech, Inc.
$1,805
PFIZER INC.
$737
Astellas Pharma US Inc
$706
Antares Pharma, Inc.
$593
Sumitomo Pharma America, Inc.
$542
Dendreon Pharmaceuticals LLC
$461
Boston Scientific Corporation
$451
Myovant Sciences Inc.
$422
AngioDynamics, Inc.
$419
BOSTON SCIENTIFIC CORPORATION
$393
Teleflex LLC
$388
Philips Electronics North America Corporation
$303
Endo Pharmaceuticals Inc.
$287
PROCEPT BioRobotics Corporation
$274
Myriad Genetic Laboratories, Inc.
$195
180 Medical, Inc.
$188
AstraZeneca Pharmaceuticals LP
$176
Foundation Medicine, Inc.
$176
UROVANT SCIENCES INC
$170
Blue Earth Diagnostics Limited
$168
Medtronic USA, Inc.
$166
Bayer HealthCare Pharmaceuticals Inc.
$153
Clarus Therapeutics Inc.
$153
UROGEN PHARMA, INC.
$147
Astellas Pharma Global Development
$145
Laborie Medical Technologies Corp.
$137
Novartis Pharmaceuticals Corporation
$114
DePuy Synthes Sales Inc.
$100
Canon Medical Systems USA, Inc.
$100
Janssen Products, LP
$99
Coloplast Corp
$99
NxThera, Inc.
$95
AbbVie, Inc.
$94
BIOTISSUE HOLDINGS INC.
$84
UroGen Pharma, Inc.
$83
Merck Sharp & Dohme Corporation
$83
Supernus Pharmaceuticals, Inc.
$79
MENARINI SILICON BIOSYSTEMS, INC.
$72
Allergan Inc.
$69
BLUEWIND MEDICAL
$65
EDAP TECHNOMED INC
$63
UroViu Corporation
$62
InSightec,Inc
$62
Clinical Laserthermia Systems Americas Inc.
$60
Merck Sharp & Dohme LLC
$56
TOLMAR Pharmaceuticals, Inc.
$55
Tolmar, Inc.
$53
ABBVIE INC.
$52
Smith+Nephew, Inc.
$49
Novo Nordisk Inc
$47
Progenics Pharmaceuticals, Inc.
$47
Amgen Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$44
Ambu Inc.
$44
Hollister Incorporated
$43
Zyla Life Sciences
$41
Aytu BioScience, Inc
$39
Ferring Pharmaceuticals Inc.
$38
Augmenix, Inc.
$38
Medtronic, Inc.
$36
Retrophin, Inc.
$36
Sun Pharmaceutical Industries Inc.
$36
TherapeuticsMD, Inc.
$36
Travere Therapeutics, Inc.
$32
Egalet US Inc
$28
Davol Inc.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Verity Pharmaceuticals Inc.
$25
Abbott Laboratories
$22
E.R. Squibb & Sons, L.L.C.
$22
Endo USA, Inc.
$20
Cook Medical LLC
$16
Baudax Bio Inc.
$15
Levita Magnetics International Corp
$15
Kowa Pharmaceuticals America, Inc.
$14
SRS Medical Systems, Inc.
$14
Avadel Specialty Pharmaceuticals, LLC
$13
Janssen Scientific Affairs, LLC
$13
Zyla Life Sciences, Inc.
$13
Duchesnay USA Incorporated
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 48.9% of total payments
Associated products mentioned in payments ›
(1211) Allura Xper FD 20 · (815) Thiola · ADSTILADRIN · ANJESO · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BALVERSA · BIOINTRAFIX · BOTOX THERAPEUTIC · CYSTO-NEPHRO VIDEOSCOPE · Cellsearch · Cook Medical Extractors · Da Vinci Surgical System · ELIGARD · ERLEADA · EVENITY · Erleada · Exablate · FARXIGA · FOUNDATIONONE · FOUNDATIONONE CDX · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL ONCOLOGY · GENERAL - BPH · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · GRAFIX PL · GREENLIGHT · ILLUCCIX · IMVEXXY · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LIGASURE · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · MOBILE LASER UNIT · MYRBETRIQ · Magnetic Surgery · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · OPDIVO · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · Osphena · Otrexup · PLUVICTO · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Proclaim Family of SCS IPGs · Prolia · REVI · RYBREVANT · Rezum · Rezum Generator · Rybelsus · SPACEOAR VUE · SPRIX · Saxenda · Seglentis · SpaceOAR · SpaceOAR VUE System - 10mL · SpeediCath · Stravix · TLANDO · TOVIAZ · Thiola · Trelstar · Tulsa-Pro · UROLIFT · Uro-G Flexible Cystoscope · UroCuff · UroLift · UroLift System · Uronav · VaPro Plus Pocket · VaPro Pocket · Vantage Orian · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (41%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for urology physician in TX.

Equivalent to $1,297 per 100 Medicare services performed
Looking for a urology physician in San Antonio?
Compare urology physicians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
100
Per 100K population
4.9
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kella is a clinical cardiology specialist, with above-average Medicare volume (top 25% in TX), and high industry engagement (speaking/promotional, top 5%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kella experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Kella performed 1,156 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kella receive payments from pharmaceutical companies?
Yes. Dr. Kella received a total of $61,808 from 88 companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kella's costs compare to other urology physicians in San Antonio?
Dr. Kella's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kella) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →